Use of Pirlindole for the treatment of diseases which are characterized by proliferation of T-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
Details for Australian Patent Application No. 2005300727 (hide)
International Classifications
Event Publications
3 May 2007 PCT application entered the National Phase
PCT publication WO2006/048242 Priority application(s): WO2006/048242
2 April 2009 Assignment before Grant
Switch Biotech AG The application has been assigned to Switch Biotech LLC
15 July 2010 Application Accepted
Published as AU-B-2005300727
11 November 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005300725-Device for the treatment of wounds using a vacuum
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser